Improving Self-Efficacy, Resolving Inflammaging Allo HSCT Survivors in Personal Training

CompletedOBSERVATIONAL
Enrollment

25

Participants

Timeline

Start Date

September 10, 2018

Primary Completion Date

March 31, 2021

Study Completion Date

March 31, 2021

Conditions
Allogeneic HCT Survivors
Interventions
OTHER

10 Weeks of Strength Trailing

"Week 1 (pre training session): self efficacy survey; 5-point frailty assessment\*; diet survey; metabolic assessment; Functional status and body composition; blood and stool sample~Week 5: self efficacy survey; Functional status and body composition~Week 10: self efficacy survey; 5-point frailty assessment\*; diet survey; metabolic assessment; Functional status and body composition; blood and stool samples"

OTHER

Group Nutrition Discussion: week 1, week 5 and week 10

"Week 1 (pre training session): self efficacy survey; 5-point frailty assessment\*; diet survey; metabolic assessment; Functional status and body composition; blood and stool sample~Week 5: self efficacy survey; Functional status and body composition~Week 10: self efficacy survey; 5-point frailty assessment\*; diet survey; metabolic assessment; Functional status and body composition; blood and stool samples"

Trial Locations (1)

55455

Masonic Cancer Center, University of Minnesota, Minneapolis

All Listed Sponsors
lead

Masonic Cancer Center, University of Minnesota

OTHER

NCT03609203 - Improving Self-Efficacy, Resolving Inflammaging Allo HSCT Survivors in Personal Training | Biotech Hunter | Biotech Hunter